 WEST LAFAYETTE, Ind., May 05, 2021 GLOBE NEWSWIRE -- Inotiv, Inc. NASDAQ:NOTV the Company, We, Our or Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced financial results for the three months Q2 FY 2021 and six months H1 FY 2021 ended March 31, 2021. 